Matches in SemOpenAlex for { <https://semopenalex.org/work/W2510110914> ?p ?o ?g. }
- W2510110914 endingPage "4935" @default.
- W2510110914 startingPage "4930" @default.
- W2510110914 abstract "A novel series of 2',4'-dimethyl-[4,5'-bithiazol]-2-yl amino derivatives were found by high throughput screening of the TRPV4 receptor, at which these compounds showed competitive antagonist potential against 4α-phorbol 12,13-didecanoate (4αPDD) as the selective TRPV4 agonist and showed excellent selectivity for TRPV1, N-type and L-type calcium ion channels, but poor ADME profile. In our SAR strategy, we found that the lead molecule 1 also having the unique 3-oxa-9-azabicyclo [3.3.1] nonan-7-one on the right part showed potent TRPV4 antagonist activity, good solubility at pH 6.8, good microsomal stability for human and better ADME profile including oral bioavailability. Moreover, compound 1 had an analgesic effect in Freund's Complete Adjuvant (FCA) induced mechanical hyperalgesia model in guinea pig. In this letter, we report a lead optimization process to identify the lead compound 1 (Fig. 1)." @default.
- W2510110914 created "2016-09-16" @default.
- W2510110914 creator A5003675418 @default.
- W2510110914 creator A5008127241 @default.
- W2510110914 creator A5009968674 @default.
- W2510110914 creator A5010956648 @default.
- W2510110914 creator A5014109550 @default.
- W2510110914 creator A5016014441 @default.
- W2510110914 creator A5016679916 @default.
- W2510110914 creator A5023352041 @default.
- W2510110914 creator A5023426659 @default.
- W2510110914 creator A5025730516 @default.
- W2510110914 creator A5026379462 @default.
- W2510110914 creator A5029023766 @default.
- W2510110914 creator A5030760398 @default.
- W2510110914 creator A5034730667 @default.
- W2510110914 creator A5038248427 @default.
- W2510110914 creator A5056051352 @default.
- W2510110914 creator A5056543337 @default.
- W2510110914 creator A5062109041 @default.
- W2510110914 creator A5069478495 @default.
- W2510110914 creator A5071891873 @default.
- W2510110914 creator A5077787674 @default.
- W2510110914 creator A5082263631 @default.
- W2510110914 creator A5084190741 @default.
- W2510110914 date "2016-10-01" @default.
- W2510110914 modified "2023-10-18" @default.
- W2510110914 title "Discovery of novel 2′,4′-dimethyl-[4,5′-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 1" @default.
- W2510110914 cites W1545384325 @default.
- W2510110914 cites W1966740493 @default.
- W2510110914 cites W1985474963 @default.
- W2510110914 cites W1988860455 @default.
- W2510110914 cites W1992001407 @default.
- W2510110914 cites W1992601827 @default.
- W2510110914 cites W1996957421 @default.
- W2510110914 cites W1998214061 @default.
- W2510110914 cites W2020877995 @default.
- W2510110914 cites W2033706178 @default.
- W2510110914 cites W2033842010 @default.
- W2510110914 cites W2038289426 @default.
- W2510110914 cites W2044474278 @default.
- W2510110914 cites W2050663388 @default.
- W2510110914 cites W2066559312 @default.
- W2510110914 cites W2070056663 @default.
- W2510110914 cites W2072942836 @default.
- W2510110914 cites W2086434606 @default.
- W2510110914 cites W2126595561 @default.
- W2510110914 cites W2128158693 @default.
- W2510110914 cites W2134182567 @default.
- W2510110914 cites W2145692204 @default.
- W2510110914 cites W2149429155 @default.
- W2510110914 cites W2150070295 @default.
- W2510110914 cites W2165344509 @default.
- W2510110914 cites W2168502120 @default.
- W2510110914 doi "https://doi.org/10.1016/j.bmcl.2016.09.013" @default.
- W2510110914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27637151" @default.
- W2510110914 hasPublicationYear "2016" @default.
- W2510110914 type Work @default.
- W2510110914 sameAs 2510110914 @default.
- W2510110914 citedByCount "8" @default.
- W2510110914 countsByYear W25101109142017 @default.
- W2510110914 countsByYear W25101109142019 @default.
- W2510110914 countsByYear W25101109142020 @default.
- W2510110914 countsByYear W25101109142021 @default.
- W2510110914 countsByYear W25101109142023 @default.
- W2510110914 crossrefType "journal-article" @default.
- W2510110914 hasAuthorship W2510110914A5003675418 @default.
- W2510110914 hasAuthorship W2510110914A5008127241 @default.
- W2510110914 hasAuthorship W2510110914A5009968674 @default.
- W2510110914 hasAuthorship W2510110914A5010956648 @default.
- W2510110914 hasAuthorship W2510110914A5014109550 @default.
- W2510110914 hasAuthorship W2510110914A5016014441 @default.
- W2510110914 hasAuthorship W2510110914A5016679916 @default.
- W2510110914 hasAuthorship W2510110914A5023352041 @default.
- W2510110914 hasAuthorship W2510110914A5023426659 @default.
- W2510110914 hasAuthorship W2510110914A5025730516 @default.
- W2510110914 hasAuthorship W2510110914A5026379462 @default.
- W2510110914 hasAuthorship W2510110914A5029023766 @default.
- W2510110914 hasAuthorship W2510110914A5030760398 @default.
- W2510110914 hasAuthorship W2510110914A5034730667 @default.
- W2510110914 hasAuthorship W2510110914A5038248427 @default.
- W2510110914 hasAuthorship W2510110914A5056051352 @default.
- W2510110914 hasAuthorship W2510110914A5056543337 @default.
- W2510110914 hasAuthorship W2510110914A5062109041 @default.
- W2510110914 hasAuthorship W2510110914A5069478495 @default.
- W2510110914 hasAuthorship W2510110914A5071891873 @default.
- W2510110914 hasAuthorship W2510110914A5077787674 @default.
- W2510110914 hasAuthorship W2510110914A5082263631 @default.
- W2510110914 hasAuthorship W2510110914A5084190741 @default.
- W2510110914 hasConcept C114373084 @default.
- W2510110914 hasConcept C155164980 @default.
- W2510110914 hasConcept C160145004 @default.
- W2510110914 hasConcept C170493617 @default.
- W2510110914 hasConcept C181389837 @default.
- W2510110914 hasConcept C185592680 @default.
- W2510110914 hasConcept C202751555 @default.
- W2510110914 hasConcept C2776885963 @default.
- W2510110914 hasConcept C2777752112 @default.